首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1345387

全球獸醫診斷市場 - 2023-2030

Global Veterinary Diagnostics Market - 2023-2030

出版日期: 2023年09月06日 | 出版商:

DataM Intelligence | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概況

2022 年，全球獸醫診斷市場達到71 億美元，預計到2030 年將實現利潤豐厚的成長，達到136 億美元。全球獸醫診斷市場預計在預測期內（2023-2023 年）年複合成長率為8.7% 。 2030）。

獸醫診斷對於動物健康至關重要，可以在健康問題變得嚴重之前發現它們，並可以更快地進行診斷和治療計劃。傳統診斷是檢查血液、組織、尿液或糞便中是否存在蛋白質、抗體、疾病或總體健康的一般標誌物。數位診斷通過發現人類專家可能忽視的健康數據趨勢，釋放該技術的預防能力，為早期疾病診斷開闢新途徑。人工智慧和其他尖端方法意味著在不斷增加的數據量中發現危險模式的潛力更大。

此外，獸醫疾病的增加、全球收養寵物數量的增加以及其他因素有助於擴大獸醫診斷市場規模。由於美國和加拿大等國家技術進步的大幅提升，北美地區的市場需求不斷增加，Ringbio、Virbac、PetDx 等重要參與者在市場上積極營運。

市場動態

全球收養寵物數量的增加將推動市場成長

全球收養寵物數量的不斷增加推動了全球獸醫診斷市場的發展。例如，根據 ASPCA 的數據，每年約有 630 萬隻伴侶動物進入美國全國的動物收容所。其中，大約 310 萬隻是狗，340 萬隻是貓。每年大約收養 410 萬隻收容動物（200 萬隻狗和 210 萬隻貓）。

此外，狗和貓等寵物也以提供陪伴和情感支持而聞名。尤其是在困難時期，例如 COVID-19 大流行，當人們花更多的時間在家裡並感到孤立時，人們渴望有寵物陪伴。大量研究表明，與寵物相處可以幫助人們應對壓力、焦慮和抑鬱。

隨著人們越來越意識到寵物對心理健康的好處，越來越多的人尋找寵物來提高他們的幸福感。由於社交媒體平台上以寵物為中心的材料的流行，寵物收養人數有所增加。在看到可愛且令人安慰的寵物影片和照片後，人們對養寵物更感興趣。因此，上述因素有助於推動市場成長。

寵物疾病患病率不斷上升

在全球範圍內，寵物疾病患病率的上升及其向人類的傳播支持了市場的擴張。人畜共患疾病的患病率上升及其向人類的傳播、寵物收養和獸醫保健專業人員數量的增加以及對獸醫疾病診斷的更多研究正在推動市場擴張。

例如，根據《Faculty Reviews 2022》發表的一項研究，超過 63% 的人類感染源於人畜共患，而另外 45% 的感染要么是由非人畜共患來源發展而來，要么與人類共同進化。幾種人畜共患疾病最近爆發並損害了全球人口。因此，寵物疾病的增加促進了市場的成長。

寵物護理成本增加和獸醫短缺

然而，寵物護理成本的增加和獸醫的短缺預計將阻礙獸醫診斷市場的成長。美國勞工統計局職業就業和工資數據顯示，2021 年 5 月，只有 77,260 名獸醫在為 9050 萬個養寵物的美國家庭執業。

此外，根據美國防止虐待動物協會的數據，根據寵物的類型和大小，養寵物的平均費用每年從 700 美元到 1,100 美元不等。因此，它將減緩預測期內全球獸醫診斷市場的成長。

Market Overview

The global veterinary diagnostics market reached US$ 7.1 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 13.6 billion by 2030. The global veterinary diagnostic smarket is expected to exhibita CAGR of 8.7% during the forecast period (2023-2030).

Veterinary diagnostics are crucial for animal health, detecting health issues before they become serious and allowing for faster diagnosis and treatment planning. Traditional diagnosis is the examination of blood, tissue, urine, or faeces for the presence of proteins, antibodies, disease, or general markers of overall health. Digital diagnostics unleash the technology's preventative capacity by spotting trends in wellness data that human specialists may overlook, opening up new avenues for early disease diagnosis. Artificial intelligence and other cutting-edge approaches mean more potential to spot danger patterns in ever-increasing data volumes.

Additionally, the rise of veterinary diseases, growing number of pets adopted worldwide and other factors helps to grow the veterinary diagnostics market size. Due to the massive rise in technological advancements in countries like the U.S. and Canada, the market is seeing an increase in demand from North American regions with significant key players like Ringbio, Virbac, PetDx, and others actively operating in the market.

Market Dynamics

Increasing Number of Pets Adopted Worldwide will Rise the Market Growth

The growing number of pets adopted worldwide fuels the global veterinary diagnostics market. For instance, according to ASPCA, approximately 6.3 million companion animals enter U.S. animal shelters nationwide every year. Of those, approximately 3.1 million are dogs and 3.4 million are cats. Approximately 4.1 million shelter animals are adopted each year (2 million dogs and 2.1 million cats).

Additionally, Pets, such as dogs and cats, are also known for offering companionship and emotional support. Especially during difficult times, such as the COVID-19 pandemic, when people were spending more time at home and feeling isolated, individuals craved the company of a pet. Numerous studies have demonstrated that engaging with pets can help people cope with stress, anxiety, and depression.

As individuals become more aware of the benefits of pets for mental health, more people sought out pets to boost their well-being. Pet adoption has increased due to the popularity of pet-focused material on social media platforms. People were more interested in owning pets after seeing adorable and comforting pet videos and photographs. Thus above factors helps to drive the market growth.

The Rising Prevalence of Pet Animal Diseases

Globally, the rising prevalence of pet animal illnesses and their transmission to humans supported market expansion. The rising prevalence of zoonotic illnesses and their transmission to humans, increased pet adoptions and the number of veterinary healthcare professionals, and more research into veterinary disease diagnosis are driving market expansion.

For instance, according to a study published in the Faculty Reviews 2022, more than 63% of human infections have zoonotic origins, whereas the other 45% have either developed from non-zoonotic sources or co-evolved with humans. Several zoonotic-origin illnesses have recently resulted in an outbreak and have damaged the global human population. As a result, the rise of pet animal diseases contributes to market growth.

The Increasing Pet Care Costs and Shortage of Veterinarians

However, the increasing pet care costs and shortage of veterinarians are anticipated to hinder the growth of the veterinary diagnostics market. The U.S. Bureau Of Labor Statistics Occupational Employment and Wages, in May 2021, indicated that only 77,260 veterinarians are practicing for the 90.5 million U.S households with pets.

Also, the average cost of owning a pet can range from $700 to $1,100 per year, as per the type and size of pet, according to the American Society for the Prevention of Cruelty to Animals. Thus, it will slow the global veterinary diagnostics market growth in the forecast period.

Segment Analysis

The global veterinary diagnostics market is segmented based on product type, animal type, technology, application, end user and region.

The Analyzers Segment Accounted for Approximately 41.07% of the Veterinary DiagnosticsMarket Share

Veterinary diagnostics analyzers are extremely important in the field of veterinary medicine. These advanced tools are meant to perform numerous diagnostic tests and analyses on animal samples, assisting veterinarians in accurately diagnosing diseases and monitoring their patients' health state.

Additionally, the strategies followed by companies helps to boost the segment growth. For instance, on December 21, 2022, EKF Diagnostics, a global in vitro diagnostics firm, has announced the launch of a new version of their Lactate Scout analyzer, specifically tailored for use in veterinary settings. Lactate Scout Vet employs the same tried-and-true technology that was first created to equip professional sports coaches and athletes with a precise and user-friendly handheld lactate test.

Additionally, in Feburary 2023, VolitionRx Limited, an epigenetics firm, has announced that their Nu.Q Vet Cancer Test is currently available for pre-order through Heska Corporation to veterinarians at the point-of-care. Heska's Nu.Q Canine Cancer Screen and Monitor Test will be run using Heska's proprietary Element i + Immunodiagnostic Analyzer, a point-of-care platform that gives veterinarians with on-site testing that is speedy, accurate, low cost, and simple to use. Thus, the aforementioned variables drive segment expansion.

Geographical Penetration

North America Accounted for Approximately 43.4% of the Market Share in 2022

Growing pet adoptions, increased expenditure on pet health, and product releases by companies all contribute to the region's success. For instance, in July 2022, PSIvet, the nation's largest veterinary group purchasing organisation, has announced an agreement with Bionote USA, a developer of quantitative, point-of-care veterinary analyzers and biomarker assays.

The collaboration will lower the cost of Bionote USA's Vcheck series of analyzers and tests for PSIvet's 5,000-plus veterinary practises. The Vcheck V200 analyzer and tests can be utilised as a supplement to a veterinary clinic's point-of-care lab for speedier diagnosis and treatment plan initiation, as well as significant cost savings per test.

Additionally, on April 19, 2022, Zoetis announced the inclusion of artificial intelligence (AI) blood smear testing to its multi-purpose platform, Vetscan ImagystTM, as its latest diagnostic breakthrough. Vetscan Imagyst, which will be available in September 2020, is a first-of-its-kind technology with a wide range of applications, including AI faecal analysis, digital cytology image transfer, and now AI blood smear - ultimately assisting veterinarians in broadening in-clinic diagnostic offerings to provide the best possible care for dogs and cats. Thus, the aforementioned reasons promote the region's growth.

Competitive Landscape

The major global players in the veterinary diagnostics market Zoetis, Thermo Fisher Scientific, Covetrus, Inc, PetDx, HORIBA UK Limited, Ringbio, Virbac, IDVet, Abaxis, Heska Corporation and others.

COVID-19 Impact Analysis

COVID- 19 pandemic has positively impacted the global veterinary diagnostics market growth. Since the pandemic, there has been an increase in pet adoption, and more attention has been paid by the pet owner to the health of their pets. For instance, a total of 3.9 million pets were insured in the U.S. at year-end 2021, showing a 28 percent rise since 2020, according to the North American Pet Health Insurance Association's State of the Industry Report 2022.

As per the Pet Food Manufacturers' Association, a total of 3.2 million households in the UK have acquired a pet since the start of the pandemic. Thus, positively impacting the global veterinary diagnostics market growth.

By Product Type

Analyzers
Consumables

By Animal Type

Livestock
Companion

By Technology

Molecular Diagnostics
Immunodiagnostics
Clinical Biochemistry
Hematology
Other Technologies

By Application

Infectious Disease
Autoimmune Disorder
Endocrinology & Oncology
Bone and Mineral diseases
Others

By End User

Reference Laboratories
Veterinary Hospitals & Clinics
Point of care/ In-house testing
Others

By Region

North America

U.S.

Canada

Mexico

Europe

Germany

U.K.

France

Spain

Italy

Rest of Europe

South America

Brazil

Argentina

Rest of South America

Asia-Pacific

China

India

Japan

Australia

Rest of Asia-Pacific

Middle East and Africa

Key Developments

On June 29, 2023, the H50V is a new 5-part veterinary solution for cost-effective diagnostics that Boule Diagnostics is offering for the European market. It has 13 preloaded animal profiles and over 30 analysed parameters, making it a versatile system that can be used in a variety of veterinary clinics and laboratories.
In August 2022, PepiPets, a pet firm focused on at-home companion animal care, is launching a new mobile diagnostic testing service. According to a corporate announcement, the launch of this new service will allow clients to undergo diagnostic testing for their pets at home.
On November 03, 2021, With the acquisition of French distribution company DMV Imaging, FUJIFILM Europe hopes to broaden its customer offering with veterinary diagnostic products and services. With this acquisition, Fujifilm hopes to establish itself as a leading veterinary diagnostics company in France, offering a comprehensive diagnostics solution that includes not only point-of-care laboratory diagnostics but also a variety of imaging diagnostic solutions for Billions of pets served by veterinarians.

Why Purchase the Report?

To visualize the global veterinary diagnostics market segmentation based on product type, animal type, technology, application, end user and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of veterinary diagnostics market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global veterinary diagnostics market report would provide approximately 53 tables, 54 figures and 195 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Animal Type
3.3. Snippet by Technology
3.4. Snippet by Application
3.5. Snippet by End User
3.6. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing number of pets adopted worldwide will rise the market growth
  - 4.1.1.2. The rising prevalence of pet animal diseases
- 4.1.2. Restraints
  - 4.1.2.1. The increasing pet care costs and shortage of veterinarians
- 4.1.3. Opportunity
  - 4.1.3.1. Rising demand for portable and rapid diagnostic devices
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID-19
- 6.1.2. Scenario During COVID-19
- 6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. ByProduct Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 7.1.2. Market Attractiveness Index, By Product Type
7.2. Analyzers *
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Consumables

8. ByAnimal Type

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal Type
- 8.1.2. Market Attractiveness Index, By Animal Type
8.2. Livestock*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Companion

9. ByTechnology

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 9.1.2. Market Attractiveness Index, By Technology
9.2. Molecular Diagnostics *
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Immunodiagnostics
9.4. Clinical Biochemistry
9.5. Hematology
9.6. Other Technologies

10. By Application

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.1.2. Market Attractiveness Index, By Application
10.2. Infectious Disease *
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Autoimmune Disorder
10.4. Endocrinology& Oncology
10.5. Bone and Mineral diseases
10.6. Others

11. ByEnd-User

11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.1.2. Market Attractiveness Index, By End-User
11.2. Reference Laboratories *
- 11.2.1. Introduction
- 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Veterinary Hospitals & Clinics
11.4. Point of care/ In-house testing
11.5. Others

12. By Region

12.1. Introduction
- 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 12.1.2. Market Attractiveness Index, By Region
12.2. North America
- 12.2.1. Introduction
- 12.2.2. Key Region-Specific Dynamics
- 12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal Type
- 12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 12.2.8.1. U.S.
  - 12.2.8.2. Canada
  - 12.2.8.3. Mexico
12.3. Europe
- 12.3.1. Introduction
- 12.3.2. Key Region-Specific Dynamics
- 12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal Type
- 12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 12.3.8.1. Germany
  - 12.3.8.2. U.K.
  - 12.3.8.3. France
  - 12.3.8.4. Spain
  - 12.3.8.5. Italy
  - 12.3.8.6. Rest of Europe
12.4. South America
- 12.4.1. Introduction
- 12.4.2. Key Region-Specific Dynamics
- 12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal Type
- 12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 12.4.8.1. Brazil
  - 12.4.8.2. Argentina
  - 12.4.8.3. Rest of South America
12.5. Asia-Pacific
- 12.5.1. Introduction
- 12.5.2. Key Region-Specific Dynamics
- 12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal Type
- 12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 12.5.8.1. China
  - 12.5.8.2. India
  - 12.5.8.3. Japan
  - 12.5.8.4. Australia
  - 12.5.8.5. Rest of Asia-Pacific
12.6. Middle East and Africa
- 12.6.1. Introduction
- 12.6.2. Key Region-Specific Dynamics
- 12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal Type
- 12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

13. Competitive Landscape

13.1. Competitive Scenario
13.2. Market Positioning/Share Analysis
13.3. Mergers and Acquisitions Analysis

14. Company Profiles

14.1. Zoetis*
- 14.1.1. Company Overview
- 14.1.2. Product TypePortfolio and Description
- 14.1.3. Financial Overview
- 14.1.4. Key Developments
14.2. Thermo Fisher Scientific
14.3. Covetrus, Inc.
14.4. PetDx
14.5. HORIBA UK Limited
14.6. Ringbio,
14.7. Virbac
14.8. IDVet
14.9. Abaxis
14.10. Heska Corporation

LIST NOT EXHAUSTIVE